Idera Pharmaceuticals Inc Share Price Nasdaq
Equities
US45168K3068
Biotechnology & Medical Research
Sales 2021 | - | Sales 2022 | 4.86M 384M | Capitalization | 3.12M 247M |
---|---|---|---|---|---|
Net income 2021 | 98M 7.74B | Net income 2022 | -23M -1.82B | EV / Sales 2021 * | - |
Net cash position 2021 * | - 0 | Net cash position 2022 * | - 0 | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 * |
-
| Employees | - |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 38.12% |
1st Jan change | Capi. | |
---|---|---|
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+50.18% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |